Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors
Kapp, Kerstin, Volz, Barbara, Oswald, Detlef, Wittig, Burghardt, Baumann, Matthias, Schmidt, ManuelLanguage:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2019.1659096
Date:
September, 2019
File:
PDF, 4.34 MB
english, 2019